Testosterone Ethosomes for Enhanced Transdermal Delivery

REFERENCES

• Bagatell C., Bremner W. Androgens in men–uses and abuses. N. Engl. J. Med. 1996; 334: 707–714, [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Basaria S., Dobs A. Hypogonadism and androgen replacement therapy in elderly men. Am. J. Med. 2001; 110: 563–572, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Bremner W., Vitiello M., Prinz P. Loss of circadian rhythmicity in blood testosterone levels with aging in normal men. J. Clin. Endocrinol. Metab. 1983; 56: 1278–1281, [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Dayan N., Touitou E. Carriers for skin delivery of trihexylphenidyl HCl: ethosomes vs. liposomes. Biomaterials 2000; 2000: 1979–1885, [CSA]
   Google Scholar
• Dobs A., Meikle A., Arver S., Sanders S., Caramelli K., Mazer N. Pharmacokinetics, efficacy, and safety of a permeation-enhanced testosterone transdermal system in comparison with bi-weekly injections of testosterone enanthate for the treatment of hypogonadal men. J. Clin. Endocrinol. Metab. 1999; 84: 3469–3478, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Godin B., Touitou E. Ethosomes: new prospects in transdermal delivery. Crit Rev. Ther. Drug Carrier Syst. 2003; 20: 63–102, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Gooren L., Bunck M. Transdermal testosterone delivery: testosterone patch and gel. World J. Urol. 2003; 21: 316–319, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Jordan W. Allergy and topical irritation associated with transdermal testosterone administration: a comparison of scrotal and nonscrotal transdermal systems. Am. J. Contact. Dermat. 1997; 8: 108–113, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMedGoogle Scholar
• Lunenfeld B. Androgen therapy in the aging male. World J. Urol. 2003; 21: 292–305, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Marbury T., Hamill E., Bachand R., Sebree T., Smith T. Evaluation of the pharmacokinetic profiles of the new testosterone topical gel formulation, Testim compared to AndroGel. Biopharm. Drug. Dispos. 2003; 24: 115–120, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Meikle A., Mazer N., Moellmer J., Stringham J., Tolman K., Sanders S., Odell W. Enhanced transdermal delivery of testosterone across nonscrotal skin produces physiological concentrations of testosterone and its metabolites in hypogonadal men. J. Clin. Endocrinol. Metab. 1992; 74: 623–628, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Paolino D., Mardente D., Calvagno M., Iannone M., Fresta M. (2004) An in-vivo evaluation of ethosomes for dermal administration of a natural anti-inflammatory agent as ammonium glycyrrhizinate. European Conference of Drug Delivery and Pharmaceutical Technology. May, 10–122004. Seville, Spain
   Google Scholar
• Samour C., Krauser S., Gyurik R. Hormone replacement therapy drug formulations for topical application to the skin. U.S. Patent 5,968,919, 1999
   Google Scholar
• Steidle C., Schwartz S., Jacoby K., Sebree T., Smith T., Bachand R., the North American AA2500 T Gel Study Group. AA2500 testosterone gel normalizes androgen levels in aging males with improvements in body composition and sexual function. J. Clin. Endocrinol. Metab. 2003; 88: 2673–2681, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Tan R., Culberson J. An integrative review on current evidence of testosterone replacement therapy for the andropause. Maturitas 2003; 45: 15–27, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Touitou E., Wartenfeld R. Transderm. Life Sci. 1987; 40: 1, [CROSSREF], [CSA]
   PubMedGoogle Scholar
• Touitou E. Composition for applying active substances to or through the skin. U.S. Patent 5,540,934, 1996
   Google Scholar
• Touitou E., Dayan N., Bergelson L., Godin B., Eliaz M. Ethosomes—novel vesicular carriers for enhanced delivery: characterization and skin penetration properties. J. Control. Rel. 2000a; 65: 403–418, [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Touitou E., Godin B., Weiss C. Enhanced delivery of drugs into and across the skin by ethosomal carriers. Drug Dev. Res. 2000b; 50: 406–415, [CROSSREF], [CSA]
   Web of Science ®Google Scholar
• Williams A., Barry B. Penetration enhancers. Adv. Drug Deliv. Rev. 2004; 56: 603–618, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Xing Q., Lin S., Chien Y. Transdermal testosterone delivery in castrated Yucatan minipigs: pharmacokinetics and metabolism. J. Control. Rel. 1998; 52: 89–98, [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Yialamas M., Hayes F. Androgens and the ageing male and female. Best Pract. Res. Clin. Endocrinol. Metab. 2003; 17: 223–236, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Zitzmann M., Nieschlag E. Hormone substitution in male hypogonadism. Moll. Cell. Endocrinol. 2000; 161: 73–88, [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar